Environmental conditions, treatments and exposures ontology
5326 terms(s) returned
| Term Type: | Record: 1301 to 1350 of 5326 Records | Page: 27 of 107, First Previous Next Last | Show Records Per Page |
- exposure to EC 2.1.1.79 (cyclopropane-fatty-acyl-phospholipid synthase) inhibitor
- exposure to EC 2.1.2.1 (glycine hydroxymethyltransferase) inhibitor
- exposure to EC 2.2.1.6 (acetolactate synthase) inhibitor
- exposure to EC 2.3.1.21 (carnitine O-palmitoyltransferase) inhibitor
- exposure to EC 2.3.1.85 (fatty acid synthase) inhibitor
- exposure to EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor
- exposure to EC 2.5.1.15 (dihydropteroate synthase) inhibitor
- exposure to EC 2.5.1.18 (glutathione transferase) inhibitor
- exposure to EC 2.5.1.19 (3-phosphoshikimate 1-carboxyvinyltransferase) inhibitor
- exposure to EC 2.5.1.29 (geranylgeranyl diphosphate synthase) inhibitor
- exposure to EC 2.5.1.58 (protein farnesyltransferase) inhibitor
- exposure to EC 2.7.1.1 (hexokinase) inhibitor
- exposure to EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor
- exposure to EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor via ingestion
- exposure to EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor
- exposure to EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor
- exposure to EC 2.7.11.13 (protein kinase C) inhibitor
- exposure to EC 2.7.7.49 (RNA-directed DNA polymerase) inhibitor
- exposure to EC 2.7.7.7 (DNA-directed DNA polymerase) inhibitor
- exposure to EC 2.7.8.15 (UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase) inhibitor
- exposure to EC 3.1.1.1 (carboxylesterase) inhibitor
- exposure to EC 3.1.1.3 (triacylglycerol lipase) inhibitor
- exposure to EC 3.1.1.3 (triacylglycerol lipase) inhibitor via ingestion
- exposure to EC 3.1.1.7 (acetylcholinesterase) inhibitor
- exposure to EC 3.1.1.8 (cholinesterase) inhibitor
- exposure to EC 3.1.3.1 (alkaline phosphatase) inhibitor
- exposure to EC 3.1.3.11 (fructose-bisphosphatase) inhibitor
- exposure to EC 3.1.3.11 (fructose-bisphosphatase) inhibitor via ingestion
- exposure to EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor
- exposure to EC 3.1.3.41 (4-nitrophenylphosphatase) inhibitor
- exposure to EC 3.1.3.48 (protein-tyrosine-phosphatase) inhibitor
- exposure to EC 3.1.4.* (phosphoric diester hydrolase) inhibitor
- exposure to EC 3.1.4.11 (phosphoinositide phospholipase C) inhibitor
- exposure to EC 3.1.4.12 (sphingomyelin phosphodiesterase) inhibitor
- exposure to EC 3.2.1.18 (exo-alpha-sialidase) inhibitor
- exposure to EC 3.4.11.14 (cytosol alanyl aminopeptidase) inhibitor
- exposure to EC 3.4.14.2 (dipeptidyl-peptidase II) inhibitor
- exposure to EC 3.4.14.2 (dipeptidyl-peptidase II) inhibitor via ingestion
- exposure to EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor
- exposure to EC 3.4.19.3 (pyroglutamyl-peptidase I) inhibitor
- exposure to EC 3.4.21.26 (prolyl oligopeptidase) inhibitor
- exposure to EC 3.4.21.5 (thrombin) inhibitor
- exposure to EC 3.4.22.38 (cathepsin K) inhibitor
- exposure to EC 3.4.24.3 (microbial collagenase) inhibitor
- exposure to EC 3.4.24.3 (microbial collagenase) inhibitor via injection
- exposure to EC 3.4.24.83 (anthrax lethal factor endopeptidase) inhibitor
- exposure to EC 3.5.1.19 (nicotinamidase) inhibitor
- exposure to EC 3.5.1.4 (amidase) inhibitor
- exposure to EC 3.5.1.98 (histone deacetylase) inhibitor
- exposure to EC 3.5.2.6 (beta-lactamase) inhibitor
